NASDAQ
AccuStem Sciences Limited (ACMSY) has a free cash flow growth of 99.96% as of Friday, May 29, 2026. This represents a 100.28% increase compared to its 12-month average of -35152.38%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.